天津市力生制药厂
🇨🇳China
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
121
NMPA:121
Drug Approvals
Ticagrelor Dispersible Tablets
- Product Name
- 替格瑞洛分散片
- Approval Number
- 国药准字H20254350
- Approval Date
- May 27, 2025
NMPA
Perindopril and Indapamide Tablets
- Product Name
- 培哚普利吲达帕胺片
- Approval Number
- 国药准字H20244377
- Approval Date
- Jul 9, 2024
NMPA
Perindopril and Indapamide Tablets
- Product Name
- 培哚普利吲达帕胺片
- Approval Number
- 国药准字H20244378
- Approval Date
- Jul 9, 2024
NMPA
Doxazosin Mesylate Extended Release Tablets
- Product Name
- 甲磺酸多沙唑嗪缓释片
- Approval Number
- 国药准字H20244353
- Approval Date
- Jun 28, 2024
NMPA
Indapamide Sustained-release Tablets
- Product Name
- 吲达帕胺缓释片
- Approval Number
- 国药准字H20244057
- Approval Date
- Jun 18, 2024
NMPA
Valsartan and Amlodipine Tablets （I）
- Product Name
- 缬沙坦氨氯地平片(Ⅰ)
- Approval Number
- 国药准字H20223856
- Approval Date
- Nov 15, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
Clinical Trials
No trials found
News
No news found